Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial

OBJECTIVE: CONCERTO was a randomised, double-blind, parallel-armed study of methotrexate (MTX) in combination with adalimumab to assess whether an increasing trend of efficacy and decreased safety exists when increasing MTX dose in patients with early rheumatoid arthritis (RA). METHODS: Early, biolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd-Rűdiger, Kivitz, Alan J, Kupper, Hartmut, Arulmani, Udayasankar, Florentinus, Stefan, Goss, Sandra L, Rathmann, Suchitrita S, Fleischmann, Roy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431334/
https://www.ncbi.nlm.nih.gov/pubmed/24550168
http://dx.doi.org/10.1136/annrheumdis-2013-204769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431334/
https://www.ncbi.nlm.nih.gov/pubmed/24550168
http://dx.doi.org/10.1136/annrheumdis-2013-204769

Ejemplares similares